• EZ Cap™ Cre mRNA and Extrahepatic Delivery

  2026-08-13

  A translational strategy for using chemically optimized Cre recombinase mRNA as a transient, measurable recombination pulse while evaluating emerging delivery systems for tissues beyond the liver.

• Pexmetinib (ARRY-614) Cytokine Assay Workflow

  2026-08-13

  Build more informative inflammation assays with Pexmetinib (ARRY-614), a dual p38 MAPK and Tie2 inhibitor suited to cytokine, bone-marrow, and pathway studies. This workflow combines dose-response design with phospho-p38 time courses so researchers can distinguish active-site inhibition from changes in kinase dephosphorylation.

• Hydroxytyrosol: Mechanisms and Research Workflow

  2026-08-12

  Hydroxytyrosol, also called 4-(2-hydroxyethyl)benzene-1,2-diol, is an olive-derived phenolic compound used in oxidative stress, inflammation, and cardiovascular health research. A 2025 cellular study linked hydroxytyrosol with lower reactive oxygen species and lipid peroxidation, anti-inflammatory macrophage markers, and enhanced cholesterol efflux.

• Cisplatin Resistance: From DNA Damage to Strategy

  2026-08-12

  Cisplatin, or CDDP, is more than a cytotoxic benchmark: it is a mechanistic probe for DNA damage, oxidative stress, apoptosis, and chemotherapy resistance studies. This translational guide connects the TNFAIP2/KEAP1/NRF2/JNK axis with experimental design, product handling, xenograft validation, and biomarker strategy.

• Reactive Oxygen Species Assay Kit: ROS Guide

  2026-08-11

  The Reactive Oxygen Species Assay Kit uses a DCFH-DA fluorescent probe to quantify relative ROS-associated fluorescence in live cells. K2065 combines a 10 mM DCFH-DA stock with 50 mg/mL Rosup positive control, supporting reproducible oxidative stress measurement assay workflows when controls and acquisition settings are standardized.

• FGF4–FGFR1 Signaling Protects Podocytes in DKD

  2026-08-10

  This Nature Communications study identifies podocyte-derived FGF4 as an endogenous protector of glomerular structure and function in diabetic kidney disease. Genetic and recombinant-protein experiments connect FGF4 to FGFR1–AMPK–FOXO1 signaling, reduced oxidative stress and apoptosis, and improved renal outcomes in male diabetic mice.

• Palonosetron Hydrochloride in CINV and RINV

  2026-08-09

  This 2013 review explains why palonosetron hydrochloride differs from earlier 5-HT3 receptor antagonists, emphasizing its high receptor affinity, prolonged half-life, and improved control of delayed chemotherapy-induced nausea and vomiting. Its systematic synthesis also clarifies how palonosetron was positioned in antiemetic guidelines and where evidence remained incomplete, including multiple-day chemotherapy and selected radiotherapy settings.

• Nascent Cone Precursors and Human Retinoblastoma

  2026-08-08

  This study uses RB1-deficient human retinal organoids and longitudinal single-cell analysis to identify ATOH7+/RXRγ+ nascent cone precursors as the earliest cellular origin of human retinoblastoma. Its findings distinguish the retinal cells most sensitive to RB1 loss from those that ultimately initiate tumors, improving disease modeling and the search for stage-appropriate therapeutic targets.

• CHI3L1-IN-5: Assays from Binding to Cell Rescue

  2026-08-07

  CHI3L1-IN-5 (Compound Z17) is a CNS-penetrant CHI3L1 inhibitor for connecting target engagement with NF-κB signaling and astrocyte recovery. This article presents an evidence-chain framework for selecting, interpreting, and validating assays rather than repeating a conventional product overview.

• RIPA Lysis Buffer (Strong): Precision in Glioma Protein Extr

  2026-08-07

  Explore how RIPA Lysis Buffer (Strong) empowers advanced protein extraction from animal tissues, with a unique focus on glioma signaling research and epigenetic assay optimization. This article reveals critical protocol insights informed by recent discoveries in glioma biology.

• Wnt Agonist 1: Precision Control of Canonical Wnt Signaling

  2026-08-06

  Explore how Wnt agonist 1 (BML-284) enables highly specific activation of the canonical Wnt pathway for rigorous cellular differentiation and developmental biology research. This article offers a distinct, protocol-oriented analysis, highlighting mechanistic nuance and practical assay design.

• Necrostatin 2 (Nec-2): Precision RIPK2 Inhibition for Decodi

  2026-08-06

  Explore how Necrostatin 2 (Nec-2) enables precise RIPK2 inhibition to untangle necroptotic cell death mechanisms. This in-depth analysis reveals advanced assay strategies and integrates breakthrough findings on membrane dynamics, setting a new benchmark for necroptosis research.

• Chicken GSDME Drives RNA Virus-Induced Pyroptosis via Caspas

  2026-08-05

  This study identifies chicken GSDME as a central effector of pyroptosis following RNA virus infection, revealing a unique caspase-dependent mechanism distinct from mammalian systems. These findings reshape our understanding of cell death pathways in avian species and provide a foundation for targeted research on host-pathogen interactions and antiviral strategies.

• 3-Bromopyruvate and Cetuximab: Overcoming CRC Drug Resistanc

  2026-08-05

  This study demonstrates that 3-bromopyruvate (3-BP) in combination with cetuximab overcomes drug resistance in colorectal cancer (CRC) cells by inducing autophagy-dependent ferroptosis and apoptosis. Mechanistic analysis reveals restoration of FOXO3a activity as a central node in reversing resistance, offering new therapeutic insights for resistant CRC.

• Perospirone (SM-9018): Bridging Neuropsychiatric and Vascula

  2026-08-04

  This thought-leadership article delivers mechanistic insight and strategic guidance for translational researchers by dissecting the dual serotonergic-dopaminergic and vascular actions of Perospirone (SM-9018 free base). Integrating the latest findings on Kv1.5 channel inhibition with practical protocol parameters, it positions Perospirone as a cornerstone for modeling complex neuropsychiatric and cardiovascular comorbidities, highlighting both opportunities and boundaries for cross-domain research.

450 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page